BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 7626485)

  • 1. Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.
    Gupta S; Wang Y; Ramos-Garcia R; Shevrin D; Nelson JB; Wang Z
    Prostate; 2010 Oct; 70(14):1575-85. PubMed ID: 20564326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone Plus Finasteride Prevents Bone Loss without Prostate Growth in a Rodent Spinal Cord Injury Model.
    Yarrow JF; Phillips EG; Conover CF; Bassett TE; Chen C; Teurlings T; Vasconez A; Alerte J; Prock H; Jiron JM; Flores M; Aguirre JI; Borst SE; Ye F
    J Neurotrauma; 2017 Nov; 34(21):2972-2981. PubMed ID: 28338402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.
    Ding M; Lin B; Li T; Liu Y; Li Y; Zhou X; Miao M; Gu J; Pan H; Yang F; Li T; Liu XY; Li R
    Oncotarget; 2015 Apr; 6(10):7686-700. PubMed ID: 25797256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
    Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
    Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS; Cai X; Abasolo I; Wang Z
    Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finasteride for benign prostatic hyperplasia.
    Hasinski S; Miller JL; Rose LI
    Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects.
    Giudici D; Briatico G; Cominato C; Zaccheo T; Iehlè C; Nesi M; Panzeri A; di Salle E
    J Steroid Biochem Mol Biol; 1996 Jun; 58(3):299-305. PubMed ID: 8836165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.
    Prahalada S; Rhodes L; Grossman SJ; Heggan D; Keenan KP; Cukierski MA; Hoe CM; Berman C; van Zwieten MJ
    Prostate; 1998 May; 35(3):157-64. PubMed ID: 9582084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.
    di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
    Stoner E
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):375-8. PubMed ID: 1701660
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.